Braun Stacey Associates’s GE HealthCare GEHC Stock Holding History

Braun Stacey Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-155,425	Closed	-$11.5M	–	117
2025 Q2	$11.5M	Sell	155,425 -54,522	-26%	-$3.8M	0.42%	83
2025 Q1	$16.9M	Sell	209,947 -11,562	-5%	-$994K	0.69%	62
2024 Q4	$17.3M	Buy	221,509 +900	+0.4%	+$76.5K	0.65%	65
2024 Q3	$20.7M	Sell	220,609 -17,465	-7%	-$1.47M	0.79%	61
2024 Q2	$18.6M	Sell	238,074 -72,962	-23%	-$5.95M	0.72%	65
2024 Q1	$28.3M	Buy	311,036 +20,444	+7%	+$1.7M	1.12%	27
2023 Q4	$22.5M	Buy	290,592 +10,208	+4%	+$715K	1%	37
2023 Q3	$19.1M	Sell	280,384 -226	-0.1%	-$16.4K	0.93%	43
2023 Q2	$22.8M	Sell	280,610 -130,754	-32%	-$10.4M	1.06%	30
2023 Q1	$33.7M	Buy	+411,364	New	+$29.4M	0.88%	55

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Braun Stacey Associates's GEHC Position: Q3 2025 in Review

Braun Stacey Associates sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 155,425 shares — an estimated $11.5M sold.

Braun Stacey Associates first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $33.7M in Q1 2023. 1,281 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

Braun Stacey Associates reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
Braun Stacey Associates sold 155,425 GE HealthCare shares in Q3 2025, an estimated $11.5M.
Braun Stacey Associates first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
Braun Stacey Associates's GE HealthCare position peaked at $33.7M in Q1 2023.
1,281 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Braun Stacey Associates's 13F filing for Q3 2025, filed 21 Oct 2025.